Novavax
NVAX
#5561
Rank
โ‚ฌ1.12 B
Marketcap
6,90ย โ‚ฌ
Share price
2.96%
Change (1 day)
-16.67%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: โ‚ฌ1.12 Billion

As of January 2026 Novavax has a market cap of โ‚ฌ1.12 Billion. This makes Novavax the world's 5561th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.12 B18.67%
2025โ‚ฌ0.94 B-25.87%
2024โ‚ฌ1.27 B147.11%
2023โ‚ฌ0.51 B-36.68%
2022โ‚ฌ0.81 B-91.47%
2021โ‚ฌ9.55 B65.5%
2020โ‚ฌ5.77 B4921.07%
2019โ‚ฌ0.11 B-81.41%
2018โ‚ฌ0.61 B59.39%
2017โ‚ฌ0.38 B19.4%
2016โ‚ฌ0.32 B-84.32%
2015โ‚ฌ2.07 B77.89%
2014โ‚ฌ1.16 B50.53%
2013โ‚ฌ0.77 B265.96%
2012โ‚ฌ0.21 B89.5%
2011โ‚ฌ0.11 B-45.01%
2010โ‚ฌ0.20 B8.97%
2009โ‚ฌ0.18 B99.06%
2008โ‚ฌ93.51 M-33.81%
2007โ‚ฌ0.14 B-26.41%
2006โ‚ฌ0.19 B7.93%
2005โ‚ฌ0.17 B87.14%
2004โ‚ฌ95.05 M-42.55%
2003โ‚ฌ0.16 B166.39%
2002โ‚ฌ62.11 M-83.3%
2001โ‚ฌ0.37 B86.48%
2000โ‚ฌ0.19 B135.24%
1999โ‚ฌ84.78 M327.94%
1998โ‚ฌ19.81 M-60.86%
1997โ‚ฌ50.61 M63.86%
1996โ‚ฌ30.88 M

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Novavax was reported to be:

โ‚ฌ1.12 Billion
by Nasdaq info icon info icon
โ‚ฌ1.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
โ‚ฌ97.84 M-91.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.90 B 70.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.50 B-54.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ1.20 B 7.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ252.09 B 22,384.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ125.62 B 11,104.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ238.57 B 21,178.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
โ‚ฌ21.92 M-98.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ83.94 B 7,387.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ1.46 B 30.95%๐Ÿ‡บ๐Ÿ‡ธ USA